Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Macrogenics (MGNX) Change in Inventory (2021 - 2025)

Macrogenics (MGNX) has disclosed Change in Inventory for 5 consecutive years, with -$840000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Change in Inventory fell 609.09% to -$840000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $7.9 million, a 261.52% increase, with the full-year FY2025 number at $7.9 million, up 261.52% from a year prior.
  • Change in Inventory was -$840000.0 for Q4 2025 at Macrogenics, down from -$525000.0 in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $9.4 million in Q1 2025 to a low of -$894000.0 in Q3 2021.
  • A 5-year average of $811850.0 and a median of $30500.0 in 2023 define the central range for Change in Inventory.
  • Biggest YoY gain for Change in Inventory was 34811.11% in 2025; the steepest drop was 609.09% in 2025.
  • Macrogenics' Change in Inventory stood at $842000.0 in 2021, then plummeted by 56.77% to $364000.0 in 2022, then plummeted by 57.42% to $155000.0 in 2023, then increased by 6.45% to $165000.0 in 2024, then plummeted by 609.09% to -$840000.0 in 2025.
  • Per Business Quant, the three most recent readings for MGNX's Change in Inventory are -$840000.0 (Q4 2025), -$525000.0 (Q3 2025), and -$151000.0 (Q2 2025).